Where does Victoria Link Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Victoria Link Ltd. ranks #6,971 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Victoria Link Ltd. hold?

Victoria Link Ltd. holds 48 US utility patents granted between 2015 and 2025, spanning 42 technology areas.

What is Victoria Link Ltd.'s Innovation Score?

Victoria Link Ltd. has an Innovation Score of 51.9 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Victoria Link Ltd. focus on?

Victoria Link Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 24 patents, ranking #816 of 6,058 assignees active in that subclass. Grants appear in 42 CPC subclasses total.

Is Victoria Link Ltd.'s patent grant rate increasing or decreasing?

Victoria Link Ltd.'s recent grant velocity is -17% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Victoria Link Ltd.'s patents?

Victoria Link Ltd.'s patents average 15.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Victoria Link Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Victoria Link Ltd.

USPTO PatentsView assignee record - 48 granted patents across 42 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Victoria ranks #6,971 of 49,997 tracked US assignees by granted-patent volume, with 48 patents across 42 technology areas.

#6,971
of 49,997 US assignees by volume: Top 11%
by Innovation Score (51.9/100): 15.7
avg claims per patent: -17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6971 · Foreign Corporation #6,971 · 48 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 48 grants
UPPER-Q #6,971/49,997
PHOTO-FINISH Ulthera
CPC-WIDE A61P · 42 areas
INNOV-PAR 51.9/100
CLAIMS-RICH 15.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ulthera, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Victoria’s 51.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (26%) Velocity 6.1 pts (12%) Breadth 22.9 pts (44%) Claim depth 9.4 pts (18%)

Qualcomm Incorporated · highest

85
University OF… · near

52
Live Nation… · near

52
Mitsubishi Heavy… · near

52
Victoria Link · this assignee

52
Inje University… · near

52
3D Lighting… · lowest

7

What this shows Victoria's Innovation Score is 51.9/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Victoria?

Each dot is one of Victoria’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Victoria’s own 15.7 claims/patent is at or below the 18.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Victoria vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Victoria's grants concentrate

Victoria Link Ltd. is a focused PatentsView assignee: 42 CPC subclasses with 50% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (8 grants) versus a trough of 2 in 2015. By volume, Victoria sits between Ulthera, Inc. and Weta Digital Ltd..

Victoria's three-year grant acceleration

Victoria Link Ltd. shows 11 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ulthera

48
United Semiconduc…

48
Vapotherm

48
Verinata Health

48
Virent

48
Vitae Pharmaceuti…

48
Vive Health

48
Weta Digital

48
Victoria Link ◀

48

What this shows Victoria holds 48 patents at rank #6,970, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Victoria

By rank, the assignees closest to #6,970 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Victoria's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Victoria, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Victoria ranks #816 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (52 here).

Mitsubishi Heavy Industries Thermal Systems, Ltd. 52 Live Nation Entertainment, Inc. 52 Inje University Industry-academic Cooperation Foundation 52 University OF Yamanashi 52

Victoria's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Victoria Link Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	4.2%
2016	5	10.4%
2017	6	12.5%
2018	8	16.7%
2019	3	6.3%
2020	2	4.2%
2021	7	14.6%
2022	7	14.6%
2023	2	4.2%
2024	2	4.2%
2025partial year	4	8.3%

Which technologies does Victoria Link Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 24

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 20

C07D - Heterocyclic Compounds 17

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 10

Y02A - Technologies FOR Adaptation TO Climate Change 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

C07C - Acyclic OR Carbocyclic Compounds 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

Top 15 of 42 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Victoria Link Ltd.'s patent record in context - here's where to go next.

Victoria Link Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 50% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,971 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Victoria Link Ltd. against Ulthera, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.